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Constitutive expression of NF-κB 
inducing kinase in regulatory T 
cells impairs suppressive function 
and promotes instability and pro-
inflammatory cytokine production 
Fanny Polesso1, Minhazur Sarker1, Arian Anderson1, David C. Parker 1 & Susan E. Murray1,2 
CD4+Foxp3+ regulatory T cells (Tregs) are indispensable negative regulators of immune responses. 
To understand Treg biology in health and disease, it is critical to elucidate factors that affect Treg 
homeostasis and suppressive function. Tregs express several costimulatory TNF receptor family 
members that activate non-canonical NF-κB via accumulation of NF-κB inducing kinase (NIK). We 
previously showed that constitutive NIK expression in all T cells causes fatal multi-organ autoimmunity 
associated with hyperactive conventional T cell responses and poor Treg-mediated suppression. Here, 
we show that constitutive NIK expression that is restricted to Tregs via a Cre-inducible transgene 
causes an autoimmune syndrome. We found that constitutive NIK expression decreased expression 
of numerous Treg signature genes and microRNAs involved in Treg homeostasis and suppressive 
phenotype. NIK transgenic Tregs competed poorly with WT Tregs in vivo and produced pro-
inflammatory cytokines upon stimulation. Lineage tracing experiments revealed accumulation of ex-
Foxp3+ T cells in mice expressing NIK constitutively in Tregs, and these former Tregs produced copious 
IFNγ and IL-2. Our data indicate that under inflammatory conditions in which NIK is activated, Tregs 
may lose suppressive function and may actively contribute to inflammation. 
Foxp3+ regulatory CD4 T cells (Tregs) are indispensable immune regulators. Genetic lesions in Foxp3 or experi-
mental depletion of Tregs causes lethal multi-organ autoimmunity in mice and humans1. Like other T cell subsets,
Tregs are activated through TCR engagement by peptide-MHC complexes. TCR activation in Tregs, however,
leads to immunosuppressive rather than pro-infammatory functions. Tregs express a TCR repertoire skewed
towards self and commensal bacterial antigens2–6; thus, their phenotypic stability is paramount lest they become 
pathogenic themselves. Although controversy exists as to the degree of Treg stability under homeostatic and
infammatory conditions7–9, it is clear that under certain circumstances they can lose suppressive function, at
least temporarily10–16. Relieving Treg-mediated suppression permits efective immune responses to clear path-
ogens or cancer cells11,17,18, but impaired Treg homeostasis and function is associated with infammation and
autoimmunity7,19,20. 
NIK (MAP3K14) is an essential kinase that links several co-stimulatory TNF receptor family members
(TNFRs) to non-canonical NF-κB activation. These receptors include TNFR2, TNFRSF4 (CD134, OX40),
TNFRSF18 (GITR), and TNFRSF9 (CD137, 4-1BB), which all have been implicated in decreasing Treg func-
tion or phenotypic stability21–29. However, conficting reports have shown instances in which these receptors
can increase Treg numbers and/or suppressive function27,30–34. It has been difcult to tease out mechanisms that
may account for these discrepancies, in part because TNFR ligation recruits TRAFs that can activate diverse
kinases including ERK1/2, PI3K/AKT, TAB/TAK, IKK complex, and NIK35. Tere is a need to parse the efects of 
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individual intracellular signaling pathways downstream of TNFRs to identify common targets for immunother-
apy that aims to turn Tregs of or on.
We previously found that constitutive expression of NIK in all T cells impairs Treg function36. In addition, NIK
was recently identifed as a multiple sclerosis susceptibility gene in a genome-wide association study37. Moreover,
aberrations in the non-canonical NF-κB pathway downstream of NIK can lead to autoimmunity in mice36,38–42. 
Despite this growing evidence that aberrant signaling downstream of NIK in efector T cells can contribute to
autoimmune pathogenesis, the efect of NIK on Treg function is unknown.
To investigate the role of NIK in Treg function, we used mice carrying an inducible, constitutively expressed
NIK transgene. When we restricted NIK transgene expression to Tregs, mice developed an autoimmune pheno-
type characterized by poorly suppressive Tregs. Mechanistically, NIK overexpression altered Treg signature gene 
expression, impaired Treg phenotypic stability, and de-repressed pro-infammatory cytokine production by Tregs. 
Results 
NIK intrinsically impairs Treg function in vitro and in vivo. NIK transgenic (NIKtg) mice harbor a
single copy NIKf-STOP-f-GFP transgene knocked into the ROSA-26 locus. Cre expression excises the foxed STOP,
allowing co-expression of NIK and GFP, via an IRES. We previously showed that T cell restricted constitutive NIK
expression in CD4Cre/NIKtg mice activates non-canonical NF-κB in T cells and causes early onset lethal multi-or-
gan autoimmunity36. In that study, we sorted conventional T cells (Tconv) and Tregs based on CD4 and CD25
expression and found that constitutive NIK expression exerts cell-intrinsic efects on both T cell subsets that, in
combination, impair Treg suppressive function. In order to test the suppressive function of more highly purifed 
in vitro generated Tregs (iTregs), we sorted CD4+ Tconv from NIKtg/Foxp3RFP and WT/Foxp3RFP littermate con-
trol mice and cultured them in Treg-inducing conditions. During culture, we induced NIK transgene expression 
via protein transduction with TAT-Cre, which recombines the NIKf-STOP-f-GFP locus at ~60% frequency. Afer 3
days, we sorted NIKtg and WT Tregs (CD4+GFP+RFP+ and CD4+GFP−RFP+, respectively) and assessed their
ability to suppress WT CD4 Tconv cell proliferation. Consistent with our prior report, we found that NIK expres-
sion intrinsically impaired the ability of iTregs to suppress Tconv cell proliferation (Fig. 1a,b and Supplementary 
Fig. S1). We also assessed whether NIKtg natural Tregs (nTregs) had impaired suppressive function. Mixed bone 
marrow (BM) chimera recipients were reconstituted with equal numbers of BM precursors from CD4Cre/NIKtg/ 
Foxp3RFP and Ty1.1/WT/Foxp3RFP mice. Unlike CD4Cre/NIKtg mice, in which nearly all T cells express the NIK 
transgene, only half of the T cells in mixed BM chimeras express the NIK transgene. Tese mice remain healthy
and aford us the opportunity to compare NIKtg and WT Tregs isolated from the same environment36. Tis
ensured that we were measuring cell-intrinsic diferences rather than diferences secondary to an infamma-
tory environment. From these BM chimeras, we sorted NIKtg and WT Tregs directly ex vivo to >98% purity
(Supplementary Fig. S2) and assessed their ability to suppress WT CD4 Tconv cell proliferation. Although the
NIKtg nTregs exerted modest suppression, it was much less than that of WT Tregs (Fig. 1c,d and Supplementary 
Fig. S1).
To test whether NIKtg Tregs are poor suppressors of infammation in vivo, we generated mice in which the
NIK transgene is induced by Foxp3Cre. Tese mice did not succumb to the rapid, pre-weaning multi-organ auto-
immunity seen in NIKtg/CD4Cre mice36, but a small proportion died between 6 and 8 months. Necropsy revealed 
severe lung infammation, but no other organ pathology (Fig. 1e). Upon euthanasia, most of the other NIKtg mice
had also developed moderate to severe lung infammation (Fig. 1f). Tus, NIK overexpression in Tregs alone is
sufcient to cause autoimmunity. 
Microarray and microRNA array gene expression patterns in NIKtg vs. WT Tregs. We examined 
how chronic NIK expression afects global gene expression patterns using microarray and miRNA array analyses 
on RNA isolated from NIKtg and WT Tregs. Again, we sorted these cells from mixed bone marrow chimeras
reconstituted with equal proportions of CD4Cre/NIKtg BM and congenically marked WT BM to ensure that we
were measuring cell-intrinsic diferences. We also sorted CD4+ Tconv from these mice as a reference point. Using
a 1.8-fold diference cutof, we found 295 genes downregulated and 88 genes upregulated in NIKtg Tregs com-
pared to WT Tregs (Fig. 2a). Several of the downregulated genes encode Treg efector molecules, such as CTLA-4,
IL-10, LAG3, CD44, ICOS, and neuropilin-1. In addition to genes encoding Treg efector molecules, downreg-
ulated genes included cytokine and homing receptors (Il10r, Cd103, Cxcr3) and transcription factors (Hif1a,
Irf4) that have been implicated in Treg function and ftness. However, consistent with our ability to sort these
cells based on Foxp3RFP expression, Foxp3 itself was not diferent between NIKtg and WT Tregs (Supplementary 
Fig. S3). Moreover, NIKtg Foxp3+ T cells in these chimeras are clearly bona fde Tregs as assessed by their expres-
sion of the Treg markers, CD25, CTLA-4, CD39, and Helios (Supplementary Fig. S3). Although NIKtg Treg
expressed somewhat lower levels of CD25 and CTLA-4 than WT Tregs, these markers were still much higher on 
NIKtg Tregs than on WT or NIKtg Tconv (Supplementary Fig. S3).
We compared our list of genes that difered between NIKtg and WT Tregs with the list of genes that difer
between CD4+Foxp3GFP+ (Treg) and CD4+Foxp3GFP− (Tconv) populations provided by Mathis and Benoist in the
Immgen database43,44. Overall, NIKtg Tregs have a gene expression pattern consistent with identity as Tregs—of
832 total Treg signature gene changes determined by Immgen analysis, only 77 (9%) difered between NIKtg and 
WT Tregs (Fig. 2b,c). However, those Treg signature genes that did difer between NIKtg and WT Tregs revealed 
an interesting pattern. Genes typically upregulated in Tregs vs. Tconv tended to show lower expression in NIKtg
vs. WT Tregs, as depicted by less intense yellow color or blue color on the heat map (Fig. 2b). Furthermore,
of genes typically downregulated in Tregs, those diferentially expressed between NIKtg and WT Tregs were
all higher in NIKtg Tregs vs. WT Tregs, as depicted by less intense blue color or yellow color on the heat map
(Fig. 2c). 
www.nature.com/scientificreports/
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Figure 1. NIK upregulation impairs Treg suppressive function in vitro and in vivo. (a,b) iTregs: Purifed NIKtg/ 
Foxp3RFP or WT/Foxp3RFP CD4 Tconv were treated with TAT-Cre fusion protein to induce expression of the 
NIK transgene and were cultured under iTreg inducing conditions. Four days later, Foxp3RFP+ iTreg cells were 
sorted and assessed for suppressive function against CFSE-labeled WT CD4+ Tconv. (a) Histograms depict 
CFSE intensity of gated WT CD4+ Tconv; numbers indicate percent of WT CD4 Tconv that have divided at least 
once. (b) X-axis indicates Treg: Tconv ratios; y-axis indicates percent of WT CD4+ Tconv that have divided at 
least once as determined by gating as in (a). (c,d) nTregs: CD4+RFP+ WT and NIKtg nTregs were sorted directly 
from spleens of mixed BM chimera recipients that had been reconstituted with equal numbers of NIKtg/CD4Cre/ 
Foxp3RFP and WT/Ty1.1/Foxp3RFP bone marrow cells. Te sorted NIKtg and WT nTregs were assessed for 
suppressive function against WT CD4+ Tconv as in (a,b). (a–d) Data are from one representative experiment 
of 2; replicate data are shown in Supplementary Fig. S1. (e,f) Lungs from NIKtg/Foxp3Cre and WT/Foxp3Cre 
littermates were assessed for immunopathology by H&E staining. Data in (f) are pooled from 3 independent 
cohorts of mice; each data point represents the score of an individual mouse *p < 0.05. 
To statistically analyze the expression of Treg signature genes in our microarray, we used the Treg signature gene
sets generated by Immgen described above to perform gene-set enrichment analysis (GSEA)45,46. Genes that are 
upregulated in Tregs vs. Tconv were signifcantly enriched among genes we found to be regulated when compar-
ing WT vs. NIKtg Tregs (Fig. 2d). Conversely, genes that are downregulated in Tregs vs. Tconv showed a negative
enrichment score in WT vs. NIKtg Tregs, which is equivalent to positive enrichment in a NIKtg vs. WT comparison
(Fig. 2e). Tese data show that constitutive NIK expression in Tregs tends to decrease genes that are usually upreg-
ulated in Tregs and increases genes that are downregulated in Tregs. Essentially, despite normal Foxp3 expression
and an overall gene pattern consistent with a Treg phenotype, these results show that NIKtg Tregs are less “Treg-like”
than WT Tregs, which could indicate that constitutive NIK expression destabilizes the Treg phenotype. 
www.nature.com/scientificreports/
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Figure 2. Gene expression patterns in NIKtg Tregs. WT and NIKtg Tregs (CD4+CD25hi) were sorted from 
spleens of healthy mixed BM chimeric mice in which WT BM chimeric mice were reconstituted with equal 
numbers of CD4Cre/NIKtg and congenically marked WT bone marrow. Total RNA was isolated for microarray 
and miRNA analysis (Fig. 3). Data show averages of 2 biological replicates for each population except (b,c), 
which show both replicates. (a) Correlation of gene expression between WT and NIKtg Tregs. (b,c) Genes 
classically increased (b) or decreased (c) in Tregs (Immgen) that are diferentially regulated between NIK-tg 
and WT Tregs. Numbers indicate fold change versus WT Tconv. (d,e) GSEA analysis using Immgen generated 
“upregulated in Tregs vs. Tconv” and “downregulated in Tregs vs. Tconv” gene sets. Genes are ranked along the 
x-axis by their fold change in WT Tregs vs. NIKtg Tregs with yellow indicating genes higher in WT Tregs and 
blue indicating genes lower in WT Tregs (higher in NIKtg Tregs). Enrichment scores are indicated on the y-axis; 
negative enrichment score (e) indicates that the gene set is enriched in those genes that are higher in NIKtg 
Tregs than WT Tregs. NES, normalized enrichment score. For both plots, the indicated gene set is signifcantly 
enriched at nominal p-value < 0.01 and nominal FDR < 0.25. 
We also compared miRNA gene expression between NIKtg and WT Tregs. miRNA-mediated regulation is critical
for Treg function and homeostatic potential as evidenced by severe autoimmunity upon Treg-specifc deletion of the
miRNA processing components Drosha and Dicer47,48. We found 51 miRNAs that difered between NIKtg and WT
Tregs—39 were decreased in NIKtg, and 12 were increased (Fig. 3a–c). Six of these diferentially expressed miRNAs
are known to promote Treg function or homeostatic maintenance, and all 6 were downregulated in NIKtg Treg vs. WT
Tregs (Fig. 3c, Table 1). Together, these 6 miRNAs have been shown to repress IFNγ receptor signaling and IFNγ pro-
duction, maintain Foxp3 expression via repression of genes that inhibit Foxp3 expression, and increase Treg survival
signals mediated by IL-2R signaling via repression of negative regulators of this pathway (Table 1). Tus, the miRNA
landscape suggests that constitutive NIK expression may decrease Treg survival and impair Treg phenotypic stability. 
www.nature.com/scientificreports/
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Figure 3. miRNA expression patterns in NIKtg Tregs. Te same samples of RNA were used for miRNA analysis 
as for microarray analysis shown in Fig. 2. (a) Correlation of miRNA expression between WT and NIKtg Tregs. 
(b,c) miRNAs that are decreased (b) or increased (c) in NIKtg Tregs relative to WT Tregs. X-axes indicate fold-
change in miRNA expression; y-axes indicate individual miRNAs. Black bars in (b) are shown in Table 1. 
miRNA Fold changea Targets described in T cells Predicted efect of decreased miR in Tregs Citations 
miR-21 14.8 down Dnmt1, SATB1 Loss of Foxp3, acquisition of Tef phenotype 68,84,85 
miR-125a 5.5 down STAT3, IFNγ, IL-13 Decreased suppressive function, acquisition of Tef phenotype 71 
miR-146a 3.9 down STAT1 signaling Production of IFNγ 67 
miR-29b 3.4 down IFNγ Production of IFNγ 72–74 
miR-10a 2.3 down Bcl-6 Decrease in Foxp3 69,70 
miR-155 2.2 down SOCS1, SATB1 Decreased CD25-mediated survival, acquisition of Tef phenotype 85,86 
Table 1. Treg intrinsic roles of microRNAs that are diferentially expressed between NIKtg and WT Tregs. afold 
change in expression levels, NIKtg Tregs vs. WT Tregs. 
NIK intrinsically alters Treg proportions and phenotype in mixed bone marrow chimeras. In
the course of sorting Treg and Tconv cell populations for the Treg suppression assays and microarray experi-
ments, we noted that the ratio of Tregs: Tconv was lower in NIKtg than WT T cell populations within mixed
BM chimeras. To confrm this diference, we quantifed relative proportions of Tregs in mixed BM chimeras
and found a 2–3 fold decrease in the proportion of Tregs within the NIKtg CD4 compartment compared to the
WT CD4 compartment (Fig. 4a,b). Te phenotype of the NIKtg Tregs also difered from that of WT Tregs in
mixed BM chimeras. In validation of our microarray results, the protein expression level of Foxp3 itself was not
diferent between NIKtg and WT Tregs; however, CTLA-4, CD44, and CD103 protein levels were decreased in
NIKtg Tregs, as was CD25 expression (Fig. 4a,b). Tese changes were consistent among peripheral lymph nodes, 
mesenteric lymph nodes, and spleen (Fig. 4b). Tese data support the hypothesis that constitutive NIK expression
impairs Treg homeostatic potential and alters their phenotype. 
NIK antagonizes IL-2 mediated iTreg expansion and disinhibits proinflammatory cytokine pro-
duction by Tregs in vitro and in vivo. Te decreased proportion and altered gene expression of NIKtg
www.nature.com/scientificreports/
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Tregs in mixed BM chimeras suggested to us that constitutive NIK expression might intrinsically render Tregs
phenotypically unstable, allowing them to convert to an efector phenotype under infammatory conditions. To
test this, we frst sorted CD4+Foxp3RFP+ WT and NIKtg Tregs from mixed BM chimeras and tested their ability to
retain Foxp3 expression under various in vitro conditions: TCR stimulation alone or with addition of IL-2, IL-6,
APCs, or WT Tconv. Over the course of 3–6 days, there was no diference in maintenance of Foxp3 expression
between NIKtg and WT nTregs under any of these conditions (Supplementary Fig. S4). 
We did, however, fnd a diference in Foxp3 maintenance between NIKtg and WT iTregs generated in vitro. 
We purifed Tconv from NIKtg-Foxp3RFP mice and cultured them in Treg-inducing conditions following TAT-Cre
treatment to mediate NIK transgene expression as in Fig. 1a,b. Afer 3 days, we sorted CD4+Foxp3RFP+ NIKtg
and WT iTregs and recultured them for an additional 3 days. Afer this secondary culture period, a signifcantly
smaller proportion of NIKtg T cells remained Foxp3+ compared with WT T cells (Fig. 5a,b). Tis skewed ratio
appeared to be an efect of increased numbers of Foxp3− cells in the culture, rather than decreased numbers of
Foxp3+ cells (Fig. 5c, frst set of bars).
IL-2 is an essential survival and growth factor for Tregs, and it acts as an important regulatory circuit by
increasing the ratios of Tregs to efectors T cells that typically produce IL-249. We asked whether exogenous IL-2
could restore normal regulation to NIKtg iTreg cultures. As expected, IL-2 increased proportions and numbers
of WT iTregs, but it had no efect on proportions or numbers of NIKtg iTregs (Fig. 5a–c). We thought decreased 
CD25 expression on NIKtg Tregs might explain the lack of efect of exogenous IL-2, but unlike NIKtg nTregs
directly ex vivo, NIKtg iTregs generated in vitro expressed normal levels of CD25 (Fig. 5d). Te high numbers of 
Foxp3− Tconv in NIKtg secondary cultures in the absence of exogenous IL-2 (Fig. 5c, lef bars) suggested a cel-
lular source of IL-2. Supernatant from cultures without exogenous IL-2 showed high levels of IL-2 in NIKtg but
not WT cultures (Fig. 5e and Supplementary Fig. S5). In addition, intracellular cytokine staining showed that in
secondary NIKtg T cell cultures both Foxp3+ and Foxp3− cells produced IL-2 (Fig. 5f and Supplementary Fig. S5).
Tus, despite producing their own IL-2, IL-2 does not provide a survival advantage to NIKtg Tregs, which may
upset normal negative feedback mechanisms.
A hallmark of Tregs is Foxp3-mediated suppression of pro-inflammatory gene transcription, includ-
ing IL-250–53, so it was surprising that the Foxp3+ population of cultured NIKtg iTregs made IL-2 upon TCR
stimulation. To determine if constitutive NIK expression in vivo endows nTregs with the capacity to produce
pro-infammatory mediators, we assessed IL-2 and IFNγ production directly ex vivo in T cells from mixed BM
chimeras. Approximately 25% of WT Tconv (CD4+Foxp3−) produced IFNγ and/or IL-2 upon stimulation with
PMA + ionomycin, and these resided in the CD44hi memory compartment (Fig. 6). Fewer than 15% of WT Tregs
produced these cytokines upon stimulation. In contrast, nearly three quarters of NIKtg Tconv produced IFNγ
and/or IL-2, and over 90% of NIKtg Tregs did so (Fig. 6 and Supplementary Fig. S6). Tus, NIK expression intrin-
sically allows Tregs to produce pro-infammatory cytokines despite Foxp3 expression. 
Lineage tracing reveals expansion of inflammatory ex-Foxp3+ cells when NIK overexpression
is Treg restricted. In severe infammatory conditions, Tregs have been shown both to secrete cytokines and
to lose Foxp3 expression7,11. Despite stable Foxp3 expression of nTregs in vitro, we thought that over time NIKtg
Tregs may lose Foxp3 expression in vivo and subsequently contribute to the lung pathology in mice when NIK
is driven by Foxp3Cre. To track loss of Foxp3 expression in vivo, we crossed Foxp3Cre mice to ROSA26f-STOP-YFP 
lineage tracing mice (hereafer referred to as Foxp3Cre/R26YFP). In these mice, once a cell expresses Foxp3 it is
marked by permanent YFP expression, so that YFP+Foxp3− expression defnes cells that once expressed Foxp3,
but subsequently lost it7. We bred Foxp3Cre/R26YFP to NIKtg mice and assessed proportions of YFP+ cells that
had retained or lost Foxp3 expression. Te proportion of YFP+Foxp3− (ex-Foxp3+) T cells in NIKtg mice was
much larger than in WT littermate controls, and this population expanded over time in the blood (Fig. 7a,b). 
Up to about 8 months of age, the proportion of WT ex-Foxp3+ T cells hovered around 10% of YFP+ cells, while
the proportion of NIKtg ex-Foxp3+ T cells climbed from ~20% to ~70% during this same time frame (Fig. 7b). 
Interestingly, the proportion of ex-Foxp3+ T cells in WT blood increased with age afer 8 months as well, albeit
more slowly and to a lesser magnitude than in NIKtg. At euthanasia, high proportions of NIKtg ex-Foxp3+ T 
cells also were evident in the spleen and lymph nodes (Fig. 7c). Te increased proportion of NIKtg ex-Foxp3+ T 
cells was not accompanied by a concomitant loss in Foxp3+ cell numbers. Instead, both Foxp3+ and ex-Foxp3+ 
T cell numbers were higher in NIKtg compared to WT mice (Fig. 7d), but the latter were increased by a larger
margin. Tus, we think it likely that the increased proportion and numbers of ex-Foxp3+ T cells are due to a
combination of increased propensity to lose Foxp3 and increased proliferation of ex-Foxp3+ T cells. However,
we cannot rule out that increased cell death in a population of NIKtg Foxp3+ Tregs could contribute to the shif 
towards ex-Foxp3+ T cells. 
We surmised that NIK activation might provide a proliferative advantage to ex-Foxp3+ T cells. Indeed, Ki67
staining showed a higher proportion of ex-Foxp3+ T cells undergoing cell division in NIKtg compared to WT
mice, but showed no proliferative diference between NIKtg and WT Foxp3+ cells (Fig. 8a,b). Tis diference
reached statistical signifcance in one experiment and showed a trend in a second experiment (Fig. 8a top, b, and
Supplementary Fig. S7). Surprisingly, the most proliferative Foxp3+ and ex-Foxp3+ T cells were those that had
lost CD25 expression (Fig. 8a bottom). Similar proportions of WT and NIKtg Foxp3+ T cells expressed CD25,
but nearly all NIKtg ex-Foxp3+ T cells lost CD25 expression while up to 30% of WT ex-Foxp3+ T cells retained
it (Fig. 8a bottom, c). We also quantifed changes in CTLA-4 and ICOS in NIKtg Foxp3+ and ex-Foxp3+ T cells.
Similar to mixed BM chimeras, NIKtg Foxp3+ Tregs expressed less CTLA-4 and ICOS than did WT Foxp3+ 
Tregs (Fig. 8d,e). In ex-Foxp3+ T cells of both genotypes, CTLA-4 and ICOS decreased, but expression remained
signifcantly lower in NIKtg vs. WT ex-Foxp3+ T cells (Fig. 8d,f). 
Lineage tracing also allowed us to test the hypothesis that upon loss of Foxp3 expression, NIKtg T cells acquire
pro-infammatory efector function. Consistent with data from mixed BM chimeras, NIKtg Tregs in Foxp3Cre/ 
www.nature.com/scientificreports/
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Figure 4. NIKtg Treg proportions and phenotype in mixed BM chimeras. Mixed BM chimeric mice were generated
as described in Fig. 2 except that mixed BM recipients were Ty1.1 and WT BM was CD45.1. (a) Gating strategy
and representative histograms of surface molecule expression in splenocytes. Upper lef dot plot is gated on live
lymphocytes. Blue lines, WT; red lines, NIKtg. (b) Quantitation of Foxp3+ proportion within the indicated genotype
of CD4 T cells (upper lef graph) and expression of CD25, CTLA-4, and CD103 on Foxp3+ gated cells from the
indicated organs. MFI, mean fuorescence intensity; MLN, mesenteric lymph nodes; PLN, peripheral lymph nodes.
Data are from one representative experiment of 3. Bar graphs depict mean +/− SD (n=5 mice). *p<0.05. 
NIKtg mice produced more IFNγ than their WT counterparts. In the ex-Foxp3+ population the efect was even
more striking—over 75% of NIKtg ex-Foxp3+ T cells produced IFNγ (Fig. 8g,h). We also assessed IL-17, IL-4, and
IL-9 production, but found no evidence for production of these cytokines (data not shown). 
www.nature.com/scientificreports/
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Figure 5. Altered IL-2 responsiveness and IL-2 production by NIKtg Tregs. CD4+ Tconv from NIKtg/Foxp3RFP 
and WT/Foxp3RFP mice were treated with TAT-Cre and cultured under Treg-inducing conditions as in Fig. 1. 
Afer 3 days, CD4+Foxp3RFP+ cells were sorted and recultured either alone or with additional IL-2. Afer 3 
days of secondary culture, cells were assessed for maintenance of Foxp3 expression. (a) Representative fow 
cytometry plots gated on live lymphocytes. (b) Percent Foxp3+ T cells in secondary cultures supplemented with 
the indicated concentrations of recombinant IL-2. (c) Total number of Foxp3+ and Foxp3− cells in secondary 
cultures supplemented with the indicated concentrations of recombinant IL-2. (d–f) Cells not treated with IL-2 
in secondary culture were assessed for CD25 expression (d) and IL-2 production as measured by ELISA on the 
culture supernatant (e) and by intracellular cytokine stain upon restimulation with PMA + ionomycin (f). Data 
are from one representative experiment of 3 (a–d) or one representative experiment of 2 (e,f); replicate data are 
shown in Supplementary Fig. S5. Bar graphs depict mean +/− SD of triplicate culture wells. 
Discussion 
NIK is a key kinase downstream of costimulatory TNFR family members. NIK has been shown to be indispensi-
ble for acquisition of efector function and survival in conventional T cells36,54–57, but its efect in Tregs is unclear. 
Here, we report that constitutive NIK expression impairs Treg-mediated suppression of infammation, resulting
www.nature.com/scientificreports/
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Figure 6. NIKtg Tregs make pro-infammatory cytokines in vivo. Mixed BM chimera receipients were 
reconstituted with a 50:50 mix of CD4CrexNIKtg BM and congenically marked WT BM in order to directly 
compare NIKtg with WT T cells in both the Treg and Tconv compartments in the same host. Spleens were 
harvested from these mixed BM chimeras between 8 and 16 weeks post reconstitution. Treg and Tconv from 
the spleens were assessed for intracellular IFNγ and IL-2 production upon 5 hours of PMA + ionomycin 
stimulation. (a) Representative fow cytometry plots, gated as indicated afer gating on live lymphocytes. (b,c) 
Proportion of CD4+Foxp3+ and CD4−Foxp3− T cells within CD4CrexNIKtg and WT T cell populations that 
produced IFNγ (b) and IL-2 (c). Data are from one representative experiment of 2; replicate data are shown in 
Supplementary Fig. S6. Bar graphs depict average +/− SD (n = 5 mice). *p < 0.05. 
in autoimmune pathology. Treg impairment involves (i) decreased expression of Treg efector molecules and
miRNAs necessary for Treg homeostasis and phenotypic stability, (ii) aberrant pro-infammatory cytokine pro-
duction by Tregs, and (iii) increased proportions and activation status of Tregs that have lost Foxp3 and acquired 
a pro-infammatory phenotype.
Gene array experiments provided insight into the defective immunosuppressive properties conferred by con-
stitutive NIK expression in Tregs. Te global gene expression pattern in NIKtg Foxp3+ T cells clearly identifes
them as Tregs. Fewer than 10% (77/832) of Treg signature genes showed expression levels that difered between
www.nature.com/scientificreports/
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Figure 7. Constitutive NIK expression expands ex-Foxp3+ T cells in vivo. CD4 T cells from NIKtg/Foxp3Cre/ 
R26YFP and WT/Foxp3Cre/R26YFP littermates were assessed for percent ex-Foxp3+ T cells (defned as percent of 
total CD4+YFP+ cells that are Foxp3−). (a) Representative FACS plots from blood showing the gating scheme. 
(b) Percent ex-Foxp3+ T cells in blood over time. Each symbol and line represents an individual mouse. (c,d) 
Percent and number of ex-Foxp3+ T cells in indicated organs at euthanasia. mLN, mesenteric lymph nodes; 
pLN, peripheral lymph nodes. All data are from one representative experiment of 3. Bar graphs depict means 
+/− SD (n = 4 mice per group). *p < 0.05. 
NIKtg and WT Tregs. However, among those Treg signature genes that did difer between NIKtg and WT Tregs, 
a clear pattern emerged wherein genes known to be important to Treg ftness and regulatory function were dis-
proportionately decreased in NIKtg Tregs. In most cases [e.g., Ctla4, Nt5e (CD73), Ebi3 (IL-35 subunit), Nrp1
(neuropilin), Itgae (CD103), Tnfrsf9 (4-1BB), Tnfrsf18 (GITR), and Folr4 (folate receptor 4)], NIKtg Tregs retained
expression of these genes above that of WT Tconv, but at lower levels than WT Tregs. In a few cases (e.g., Cxcr3, 
Hif1a, Icos, Il10, Il10ra, Irf4, and Lag3), Treg signature genes were unchanged or even decreased in NIKtg Tregs
compared to WT Tconv. Tese changes are intrinsic to NIK expression in Tregs rather than secondary to an
infammatory environment since we performed the gene arrays on WT and NIKtg Tregs sorted from mixed bone
marrow chimeras. 
One Treg signature gene whose expression was unafected by NIK in Tregs was Foxp3 itself. How do we rec-
oncile normal Foxp3 expression levels with altered transcriptional profles? Although Foxp3 is ofen described
as the Treg master transcription factor, it is clear that Foxp3 does not directly repress or transactivate transcrip-
tion of all Treg signature genes58–60. Tus, it is not surprising that we found many Treg efector genes down-
regulated in NIKtg Tregs despite normal levels of Foxp3. However, among genes shown to be direct targets of
Foxp3-mediated transactivation58, several, including Cd44, Ctla4, Icos, and Nrp1, were downregulated in NIKtg
vs. WT Tregs. Decreased expression of these genes, despite normal Foxp3 RNA and protein expression, could
result from post-translational modifcations of Foxp3, altered expression of transcription factors that interact
with Foxp3, and/or chromatin modifcations. Both acetylation and phosphorylation have been shown to alter
Foxp3-mediated transactivation. For instance, TNFα signaling in infamed joints activates protein phosphatase
1 (PP1), which de-phosphorylates Foxp3, leading to decreased Foxp3-mediated transactivation and suppres-
sive function61. Notably, we found altered PP1 expression in NIKtg Tregs relative to WT Tregs by microarray.
Foxp3 can both antagonize and cooperate with other transcription factors, including NF-AT and NF-κB. Foxp3
cooperates with NFAT downstream of TCR signaling to increase expression of Ctla4 and Cd25 in Tregs52, and
Nfatc1, CTLA-4, and CD25 expression levels were all decreased in NIKtg Tregs. Conversely, Foxp3 normally
prevents Treg production of pro-infammatory cytokines, in part, via antagonizing the transcriptional activity
of NF-AT and NF-κB at other loci50. Perhaps increased NF-κB activation in NIKtg Tregs overwhelms the Foxp3
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Figure 8. Constitutive NIK expression alters proliferation, phenotype, and cytokine production by ex-Foxp3+ 
T cells. Lymphocytes from NIKtg/Foxp3Cre/R26YFP and WT/Foxp3Cre/R26YFP littermates were gated on Tregs 
(CD4+YFP+Foxp3+) or ex-Foxp3+ T cells (CD4+YFP+Foxp3−) as in Fig. 7 and assessed for expression of 
the indicated markers directly ex vivo (a–f) or for expression of IFNγ afer PMA + ionomycin stimulation 
(g,h). (a,d,g) Representative fow cytometry plots gated on live CD4+ lymphocytes plus additional markers 
as indicated. (b,c,e,f) Quantitation of indicated populations from pLN, mLN, and spleen. (h) Quantitation 
of IFNγ-producing T cells from spleen. Data are from one representative experiment of 3 (c–h) or one 
representative experiment of 2 (a,b); replicate data are shown in Supplemental Fig. S7. Bar graphs depict means 
+/− SD (n = 4 mice per group). *p < 0.05. 
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transrepression capacity. Ratios of opposing transcription factors, rather than absolute expression levels of a par-
ticular transcription factor, determine fate decisions in other lymphocytes. For instance, the BLIMP/bcl6 ratio
controls terminal efector vs. memory diferentiation in B cells and T cells62–64. Tus, varying nuclear ratios of
Foxp3 to other transcription factors could underlie altered function and phenotype in NIKtg Tregs despite nor-
mal Foxp3 expression. Supporting this idea, we found that NF-κB2, a positive feedback loop target of NF-κB, is 
increased in NIKtg Tregs. Tis suggests that despite Foxp3 expression, NF-κB activation in NIKtg Tregs is robust 
enough to induce gene transcription.
A non-mutually exclusive possibility is that chronic NIK expression alters Treg signature gene expression
by mechanisms independent of NF-kB activation. For instance, NIK has been shown to increase CREB stability
via phosphorylation-dependent and -independent mechanisms in hepatocytes65. In addition, IKKα—the pri-
mary target of NIK phosphorylation—can itself translocate to the nucleus and activate or repress gene expres-
sion via chromatin remodeling (e.g., phosphorylating histone H3) and via phosphorylation-dependent efects on
co-activators and co-repressors66. 
MicroRNA data from NIKtg Tregs suggested another mechanism by which chronic NIK activation could
impair Treg-mediated suppression in vivo. Of 51 diferentially regulated miRNAs, >75% were decreased in NIKtg
Tregs vs. WT Tregs. A global decrease in miRNAs due to Dicer insufciency intrinsically impairs Treg function
and homeostasis and abrogates Treg suppressive function in infammatory settings47. Moreover, specifc miRNAs
important in maintaining Treg homeostasis and suppressive function (10a, 125a, 146a, 155, 21) were all decreased
in NIKtg Tregs67–71. Of these, miR-10a and miR-21 also help maintain Foxp3 expression in Tregs68–70, and miR-29
has been shown to restrain IFNγ production in T1 cells72–74. Together, these data suggested that in addition to
impairing their suppressive function, chronic NIK activation might also decrease Treg ftness and endow Tregs
with pro-infammatory capacity.
We tested this hypothesis and found that NIKtg Tregs do indeed make copious levels of the pro-infammatory
cytokines IL-2 and IFNγ and are under-represented in mixed BM chimeras. At frst glance, this fnding seems
to contradict the observation of increased Treg numbers in Foxp3Cre/NIKtg mice (Fig. 7). However, the mixed
BM chimeric mice remain healthy due to the presence of WT Tregs36, whereas Foxp3Cre/NIKtg mice experi-
ence signifcant infammation-associated morbidity (Fig. 1). Tregs are well-known to expand in infammatory
conditions, and we previously showed that just prior to the early rapid demise of CD4Cre/NIKtg mice, Tregs are
increased36. When WT Tregs are absent, the infammatory environment causes some NIKtg Treg expansion, but 
the expanded Tregs are still insufcient to control the infammation, and ultimately a proportion loses Foxp3. It
is unclear at this time if chronic NIK activation actually increases the rate at which Tregs lose Foxp3 or expands
ex-Foxp3+ T cells (as suggested by increased Ki67 staining). Based on the survival role of NIK and non-canonical
NF-kB downstream of TNFR family members like BAFFR, it is also possible that chronic NIK activation rescues 
ex-Foxp3+ T cells from apoptosis, which would also explain the increased numbers of these cells relative to WT
ex-Foxp3+ cells. 
In summary, we found that constitutive NIK expression in Tregs causes transcriptional changes that serve to
both impair Treg suppressive function and to give Tregs a pro-infammatory phenotype. Under situations of nor-
mal host defense, activation of NIK downstream of costimulatory TNFRs on Tregs may be important to tempo-
rarily impede Tregs and allow elaboration of efective T cell immunity. However, if TNFR-mediated infammatory
signals become chronic, constitutive NIK expression in Tregs could impair negative feedback mechanisms and
contribute to immunopathology, as we observed here. Moreover, when Foxp3 is lost from Tregs under conditions
of constitutive NIK expression, those ex-Foxp3+ T cells are proliferative and capable of making pro-infammatory
cytokines. Tis is particularly dangerous given that Tregs are selected during development to be more autoreactive
than Tconv. 
Our fndings are relevant to therapeutic strategies, already in clinical trials, that aim to treat autoimmunity
and allograf responses by expanding Tregs in vivo or infusing in vitro expanded autologous Tregs75–78. Tese
strategies depend on infused Tregs maintaining their suppressive identity, but under a chronic infammatory
state, this identity could be jeopardized by activation of NIK in Tregs. Tus, the level of NIK activation could be
an important biomarker for Treg stability and predictor of treatment efcacy. Moreover, several TNF super family
ligands and receptors have been linked to autoimmunity in GWAS studies37,79,80, and recently NIK was linked to
MS in a GWAS-NR study37. Our results suggest that assessing the relationship between NIK activation and Treg
suppressive function in patients with autoimmune diseases may provide evidence for NIK as a potential thera-
peutic target for these diseases. 
Materials and Methods 
Mice. Mice were housed under specifc pathogen–free conditions at the Oregon Health and Science University
animal facility. All procedures were approved by the OHSU Institutional Animal Care and Use Committee
and were carried out in accordance with OHSU Animal Care and Use Program Standard Procedures. Ty1.1
(B6.PL-Ty1a/CyJ), CD45.1 (B6.SJL-PtprcaPepcb/BoyJ), CD4Cre (B6.Cg-Tg(CD4-Cre)1Cwi/BfuJ), Foxp3RFP 
(C57BL/6.Foxp3tm1Flv/J), Foxp3Cre (NOD/ShiLt-Tg(Foxp3-EGFP/cre)1cJbl/J), and ROSA26f-STOP-YFP (B6.129 × 1-
Gt(ROSA)26Sortm1(EYFP)Cos/J) mice were from Te Jackson Laboratory. NIKtg mice with a single copy NIKf-STOP-f-
GFP transgene knocked into the ROSA-26 locus were obtained from K. Rajewsky (Harvard Medical School, Boston,
Massachusetts, USA)81. Tese mice are now available from the Jackson Laboratory (B6.Gt(ROSA)26Sortm5(Map3k14) 
Rsky/J). All mice except Foxp3Cre are on a C57BL/6 background. In all experiments using Foxp3Cre mice, littermate 
control mice expressing Foxp3Cre, but not expressing the NIK transgene were used. 
Mixed bone marrow chimeras. Bone marrow (BM) was harvested from femurs and tibias of 11- to
18-day-old mice. Single-cell suspensions of BM were depleted of mature T cells via magnetic separation using
anti-CD3-biotin. 2.5–10×105 total BM cells were injected i.v. into lethally irradiated recipients. CD45.1 recipients
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were reconstituted with equal numbers of BM precursors from NIKtg/CD4Cre/Foxp3RFP and WT/Ty1.1/Foxp3RFP 
mice for use in in vitro Treg functional assays and microarrays. Ty1.1 recipients were reconstituted with equal
numbers of BM precursors from NIKtg/CD4Cre and WT/CD45.1 mice for use in phenotype and intracellular
cytokine staining assays. T cells from mixed chimeras were used 8–16 weeks afer reconstitution. 
Reagents and Antibodies. Recombinant IL-2, recombinant TGFβ, anti-IL-2 (54B6.1), and anti-IL-4 (11B11)
blocking antibodies were from Peprotech. Retinoic acid was from Sigma-Aldrich. Anti-IFNγ blocking antibody 
(XMG1.2) was from BioXCell. Anti-CD3 (145–2C11), anti-CD28 (37.51) and Brefeldin A were from eBiosci-
ence. Fluorescently conjugated antibodies and other fuorescent reagents used for fow cytometry were anti-CD4
(RM4-5), anti-CD25 (PC61.5), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD103 (2E7), anti-CTLA4 (UC10-4B9),
anti-Foxp3 (FJK-16S), rabbit anti-GFP (polyclonal), anti-rabbit (polyclonal), mouse anti-Ki67 (B56), anti-mouse
IgG1 (M1-14D12), anti-IFNγ (XMG1.2), anti-IL-2 (JES6-5H2), anti-IL-4 (11B11), anti-IL-9 (RM9A4), anti-IL-17
(17B7), anti-ICOS (15F9), anti-Ty1.1 (cHIS51), CFSE, and Live/Dead Aqua. All staining antibodies were from 
eBioscience except anti-CD103 (BioLegend), anti-Ki67 and anti-IL-2 (BD Biosciences), and anti-GFP (Invitrogen).
CFSE and Live/Dead Aqua were from Life Technologies. EasySep Negative Selection kits were from Stem Cell
Technologies, and Foxp3 Fix/Perm Bufer sets and Mouse IL-2 ELISA kits were from BioLegend. 
Antibody staining and flow cytometry. Spleen cell suspensions and peripheral blood were red blood cell
lysed and stained directly ex vivo or stimulated with PMA + ionomycin in the presence of Brefeldin A for 5 hours 
and then stained for surface markers and intracellular cytokines as described82. Cells were fxed and permeabi-
lized per the manufacturer’s instructions (Biolegend Foxp3 Fix/Perm Bufer kit), and anti-cytokine antibodies
were added at the same time as anti-nuclear antibodies (Foxp3 and Ki67). Cells were analyzed on an LSR II fow 
cytometer (BD Biosciences) and analyzed using FlowJo (Tree Star). 
TAT-Cre transduction and iTreg Differentiation. Magnetically purifed CD4+CD25− T cells (Tconv)
from Foxp3RFPNIKtg and Foxp3RFPWT littermates were treated with recombinant TAT-Cre fusion protein to
induce expression of the NIK transgene as previously described36,83. Briefly, CD4 T cells from NIKtg and
WT littermate mice were incubated in serum-free media with 100 μg/ml TAT-Cre for 45 minutes, washed in
serum-containing media, and cultured in vitro on anti-CD3– and anti-CD28–coated plates (5 μg/ml each) with 10
U/ml IL-2, 2–8 ng/ml TGF-β, 10 mM all-trans retinoic acid, 2 μg/ml anti–IFN-γ, and 1.4 μg/ml anti–IL-4 for 3-4 
days. iTregs (CD4+Foxp3RFP+) were then sorted on a FACSAria to >98% purity. For NIKtg cultures, an additional
GFP+ gate was used to sort those cells in which the NIK transgene had undergone Cre-mediated recombination. 
In Vitro Treg Functional Assay. NIKtg and WT Foxp3RFP+ Tregs were sorted from from iTreg cultures
as described above or sorted directly from spleens of mixed BM chimeras (Fig. S2). Varying ratios of sorted
Tregs were cultured with CFSE labeled CD45.1 (WT) CD4 Tconv, irradiated WT antigen-presenting cells, and
anti-CD3 for 3 days as described36. Treg suppressive function was measured by analyzing CFSE dilution within
the CD4 Tconv population. 
Cell sorting and RNA isolation for microarray and microRNA analyses. For each sample repli-
cate, CD4 T cells were magnetically purifed by negative selection from 3 pooled mixed BM chimera spleens.
Cells were sorted on a FACSAria to isolate Tregs and Tconv from both NIKtg and WT populations. Sorting
gates were as follows: NIKtg Tregs: CD4+Thy1.1−GFP+RFP+; NIKtg Tconv: CD4+Thy1.1−GFP+RFP−; WT 
Tregs: CD4+Ty1.1+GFP−RFP+; WT Tconv: CD4+Ty1.1+GFP−RFP−. RNA was extracted with RNeasy mini kit
(Qiagen) and the samples were submitted to the Oregon Health and Science University Gene Profling and Shared
Resource for microarray and microRNA array analyses. 
Microarray analysis. Each RNA sample was labeled using the Ambion MessageAmp Premier RNA
Amplifcation Kit and hybridized to an Illumina MouseRef 8 v2 Expression BeadChip Array. Image processing
and expression analysis were performed using Illumina BeadArray Reader and GenomeStudio (v. 2010.1) Gene
Expression module (v. 1.6.0) sofware. Intensity (.idat) fles were produced by the BeadArray reader (Illumina
scanner system). Intensity fles, along with the BeadChip decode fle (.dmap) were loaded to GenomeStudio’s
Gene Expression module to generate probe/gene level signal intensity data (normalized and raw), perform QA/
QC, and perform high level data visualization. Raw data were Lumi quantile normalized and log transformed
before applying a 1.8 fold cutof for diferential regulation between WT and NIKtg Tregs. All microarray and
microRNA array data are available at GEO with the reference number GSE80757 (http://www.ncbi.nlm.nih.gov/ 
geo/query/acc.cgi?acc = GSE80757).
To generate lists of genes that are regulated between conventional CD4+ T cells and Tregs from the Immgen
database, we used the population comparison tool and compared “T_4FP3 + 25 + _Sp” with “T_4FP3-_Sp”, sub-
mitted by T. Heng in the Benoist-Mathis lab, Joslin Diabetes Center43. We used Venny (http://bioinfogp.cnb.csic. 
es/tools/venny/index.html)44 to compare our list of genes that were regulated >1.8 fold between WT and NIKtg
Tregs with the Immgen-generated lists of genes upregulated and downregulated in Tregs vs. Tconv. For GSEA
analysis, we used these Immgen-generated lists of genes upregulated and downregulated in Tregs vs. Tconv as our
gene sets. Enrichment of these gene sets in our microarray expression dataset was performed using the Gene Set 
Enrichment Analysis sofware from the Broad Institute45,46. Te metric for ranking genes was log2 ratio of classes,
and permutation type was gene set. 
MicroRNA array analysis. Each RNA sample was labeled using the Genisphere HSR miRNA Flash Tag
Biotin protocol and hybridized to an Afymetrix GeneChip miRNA Array (v2). Image processing was performed 
www.nature.com/scientificreports/
1 4  Scientific RepoRts | 7: 14779  | DOI:10.1038/s41598-017-14965-x
 
 
 
 
 
 
 
  
  
  
   
   
  
   
 
   
 
    
  
 
    
 
   
   
 
   
   
 
   
 
   
   
  
 
   
   
 
   
 
    
   
 
   
 
   
 
   
 
      
 
  
 
   
     
   
   
 
   
 
   
 
   
 
using Affymetrix Command Console (AGCC) version 3.1.1 software, and analysis was performed using
Afymetrix miRNA QC Tool version 1.1.1.0 sofware. Image processing of sample DAT fles to generate probe
intensity CEL fles was completed in Afymetrix GeneChip Command Console (AGCC) version 3.1.1 sofware.
Each array was analyzed using the Afymetrix miRNA QC Tool version 1.1.1.0 sofware to calculate the quality
assessment metrics on non-normalized data. A multi-chip analysis incorporating all samples was performed
according to the Genisphere FlashTag Biotin HSR labeling protocol manual (28Jan10). Probeset intensities were
normalized using the Robust Multi-array Average (RMA) algorithm in Expression Console (build 1.4.1.46). Log2 
intensities were averaged across treatment types, and log ratios (NIKtg Treg/WT Treg) were calculated and trans-
formed to linear space before applying a 1.8 fold cutof for diferential regulation between WT and NIKtg Tregs. 
Statistics. Flow cytometric comparisons between NIKtg and WT T cell populations were assessed by
Students t-test. 
Histology. Mouse organs were fxed with 10% (v/v) bufered formalin and embedded in parafn. Sections
were stained with hematoxylin and eosin and blindly scored by two pathologists. 
Data Availability. All microarray and microRNA array data are available at GEO with the reference number
GSE80757 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80757). 
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